Thymic carcinoma in an adult
Keywords:
thymic carcinoma, thymectomy, mediastinal lymphadenectomy, chemotherapy, radiotherapy.Abstract
The case report of a 50 year-old patient is presented who visited the Oncology department of "Dr. Juan Bruno Zayas Alfonso"TeachingGeneralHospital inSantiago de Cuba, due to a 4 months thymic tumor. A thymectomy and mediastinal lymphadenectomy were carried out , as well as a biopsy which indicated the presence of thymic carcinoma, type II lymphoepithelioma of high degree of malignancy, stage IV A; for such a reason it was decided to carry out a treatment with chemotherapy and radiotherapy. Due to the tumor persistence the second chemotherapy line was planned, but the patient died.
Downloads
References
2. Loehrer Patrick J, Wick Mark R, Badve Sunil. Thymoma and thymic carcinoma. In: Raghavan Derek, Blanke Charles D, Johnson David H, Moots Paul L, Reaman Gregory H, Rose Peter G, et al. Textbook of uncommon cancer. 4 ed. New Jersey: Hoboken; 2012. p. 279-301.
3. Cameron Robert B, Loehrer Patrick J, Lee Percy P. Neoplasms of the mediastinum. In: DeVita, Hellman, Rosenberg’s. Cancer. Principles and practice of oncology. 10th ed. Philadelphia: Wolters Kluwer Health / Lippincott Williams and Wilkins; 2015. p. 560-9.
4. Yu Helena J, Riely G. Thymoma and thymic carcinoma. Thoracic malignancies; Pocket Oncology Notebook. Philadelphia: Lippincott Williams and Wilkins, Wolters Kluwer; 2014. p. 136-7.
5. Vieira Farias Nivaldo N, William William C, Maluf Fernando C, Buzaid A. Timoma y carcinoma tímico. Manual de Oncología Clínica (MOC). Sao Paulo: Centro Oncológico “Antonio Ermirio de Moraes”; 2015.
6. Ettinger DS, Riely GJ, Akerley W, Borghaei H, Chang AC, Cheney IT, et al. Thymomas and thymic carcinomas. Clinical Practice Guidelines in Oncology. JNCCN. 2013 [citado 05/04/2017]; 11(5). Disponible en: http://www.jnccn.org/content/11/5/562.full.pdf+html
Published
How to Cite
Issue
Section
License
All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.